SILVER SPRING, Md., US: The US Food and Drug Administration (FDA) has announced new enforcement actions to restrict the sale of ingestible fluoride drug products
SILVER SPRING, Md., US: The US Food and Drug Administration (FDA) has finalised guidance on animal studies for dental bone grafting material devices, aiming to
Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients
There’s good news for patients who don’t like the needle. St. Renatus LLC has received US Food and Drug Administration approval for its Kovanaze Nasal
The California Department of Public Health is granting dentists and their trained staff who use portable, handheld x-ray devices an exemption from prohibitions against holding
SOUTH JORDAN, Utah, August 2013 – The International Organization for Standardization (ISO) recently adopted Ultradent Products Inc.’s notched-edge shear bond strength testing method as a